Gold nanoparticles uptake and cytotoxicity assessed on rat liver precision-cut slices.

A major obstacle in the field of nanotoxicology is the development of an in vitro model that accurately predicts an in vivo response. To address this concern, rat liver precision-cut slices were used to assess the impact of 5-nm gold nanoparticles (GNPs) coated with polyvinylpyrrolidone (PVP) on the mammalian liver, following exposure to different concentrations and for a duration of up to 24 h. The presence of GNPs inside endocytotic vesicles of hepatocytes was appreciable within 30 min of their addition. After 2 h, GNPs were clearly visualized inside endosome-like vesicles within the slice, not only in hepatocytes but also in endothelial and Kupffer cells located within the first two cellular layers. This uptake did not translate into modifications of either phase I or phase II of 7-ethoxycoumarin metabolism or alter activities of cytochrome P450 toward marker substrates. Furthermore, although the GNPs were rapidly internalized, no overt signs of cytotoxicity, assessed through lactate dehydrogenase release, reduction of methylthiazolyldiphenyl tetrazolium bromide, and glutathione levels, were observed. In conclusion, the use of rat liver slices successfully enhanced nanomaterial screening and determined that PVP-coated 5-nm GNPs were biocompatible with rat liver cells.

[1]  L. Du,et al.  Potential oxidative stress of gold nanoparticles by induced-NO releasing in serum. , 2009, Journal of the American Chemical Society.

[2]  M. Frosini,et al.  CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes. , 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[3]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[4]  R. Khokha,et al.  Thinking outside the cell: proteases regulate hepatocyte division. , 2005, Trends in cell biology.

[5]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[6]  R. Gebhardt,et al.  Ligand-dependent redistribution of the IgA receptor on cultured rat hepatocytes and its disturbance by cytochalasin B. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[7]  Chao Liu,et al.  Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition , 2009, Journal of applied toxicology : JAT.

[8]  Sabine Neuss,et al.  Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. , 2009, Small.

[9]  Mark E. Davis,et al.  Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.

[10]  Mark A. Atwater,et al.  Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. , 2007, Colloids and surfaces. B, Biointerfaces.

[11]  Sanjiv S Gambhir,et al.  A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.

[12]  N. Vermeulen,et al.  Comparative cytotoxicity of N-substituted N'-(4-imidazole-ethyl)thiourea in precision-cut rat liver slices. , 2004, Toxicology.

[13]  J. Lake,et al.  Acidic vesicles in cultured rat hepatocytes. Identification and characterization of their relationship to lysosomes and other storage vesicles. , 1987, Gastroenterology.

[14]  Jinatta Jittiwat,et al.  Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. , 2010, Biomaterials.

[15]  J. Prieels,et al.  Galactose‐specific adsorptive endocytosis: an ultrastructural qualitative and quantitative study in cultured rat hepatocytes , 1984, Biology of the Cell.

[16]  Håkan Wallin,et al.  Protracted elimination of gold nanoparticles from mouse liver. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Håkan Wallin,et al.  Kupffer cells are central in the removal of nanoparticles from the organism , 2007, Particle and Fibre Toxicology.

[18]  Yanli Liu,et al.  Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. , 2004, Bioconjugate chemistry.

[19]  G. Harms,et al.  Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules , 2004, Histochemistry.

[20]  T. Pieber,et al.  Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. , 2010, Toxicology and applied pharmacology.

[21]  Hans C. Fischer,et al.  Pharmacokinetics of Nanoscale Quantum Dots: In Vivo Distribution, Sequestration, and Clearance in the Rat , 2006 .

[22]  Indrajit Roy,et al.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.

[23]  Lang Tran,et al.  Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. , 2010, Toxicology and applied pharmacology.

[24]  David Schneider,et al.  Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells , 2011, Nanotoxicology.

[25]  Deny Hartono,et al.  Autophagy and oxidative stress associated with gold nanoparticles. , 2010, Biomaterials.

[26]  A. Vickers Tissue slices for the evaluation of metabolism-based toxicity with the example of diclofenac. , 2009, Chemico-biological interactions.

[27]  P. Olinga,et al.  Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies , 2010, Nature Protocols.

[28]  M. Hashida,et al.  Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[29]  H. Norppa,et al.  Risk assessment of engineered nanomaterials and nanotechnologies--a review. , 2010, Toxicology.

[30]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[31]  S. Friedman,et al.  Molecular basis of hepatic fibrosis , 2003, Expert Reviews in Molecular Medicine.

[32]  G. Labbe,et al.  Evaluation of cultured, precision-cut rat liver slices as a model to study drug-induced liver apoptosis. , 2005, Toxicology.

[33]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[34]  N. Kotov,et al.  In vitro toxicity testing of nanoparticles in 3D cell culture. , 2009, Small.

[35]  J. Hillier,et al.  A study of the nucleation and growth processes in the synthesis of colloidal gold , 1951 .

[36]  R. Mccomb,et al.  Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. , 1968, Clinical chemistry.

[37]  H. Kolb,et al.  GalNAc/Gal‐specific rat liver lectins: their role in cellular recognition , 1984, Biology of the cell.

[38]  P. Olinga,et al.  Rat liver slices as a tool to study LPS-induced inflammatory response in the liver. , 2001, Journal of hepatology.

[39]  F. Rossi,et al.  A quantitative in vitro approach to study the intracellular fate of gold nanoparticles: from synthesis to cytotoxicity , 2009 .

[40]  Lev Dykman,et al.  Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. , 2011, Chemical Society reviews.

[41]  D. Herbert,et al.  In vivo uptake of lecithin‐coated polystyrene beads by rat hepatocytes and sinusoidal endothelial cells , 1996, The Anatomical record.

[42]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.